Frontier mental health research: psychedelics & drug studies

Each month our editorial team sifts through hundreds of papers and curates notable findings—for practitioners and informed readers who want to stay current with the evidence. Subscribe to the monthly Research Digest for expert analysis and concise summaries of key papers.

1 paper

Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study

Khalid Jadoon, S. Ratcliffe, David A. Barrett, E. Louise Thomas, Colin Stott, Jimmy D. Bell, et al.
Diabetes Care Summary & key facts 2016 246 citations

This was a small, randomized, double-blind, placebo-controlled 13-week pilot trial of two nonpsychoactive cannabis-related compounds (cannabidiol, CBD, and tetrahydrocannabivarin, THCV) in 62 people with type 2 diabetes who were not using insulin. Participants were assigned to CBD, THCV, two CBD/THCV combination doses, or placebo. Compared with placebo, THCV lowered fasting…

Cannabis and Cannabinoid Research Diet, Metabolism, and Disease Pancreatic function and diabetes
Summaries and links are for general information and education only. They are not a substitute for reading the original publication or for professional medical, legal, or other advice. Always refer to the linked source for the full study.